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Objectives: To test the hypotheses that (1) women who know that human papillomavirus (HPV) is sexually
transmitted will expect to experience higher levels of stigma, shame and anxiety if they test positive for the
virus than women who are not aware of the mode of transmission and (2) women who are aware of the high
prevalence of HPV infection will expect to experience lower levels of stigma, shame and anxiety than women
who underestimate its prevalence.
Methods: A web-based survey in which information about HPV was manipulated to generate a 262 design
(awareness that HPV is sexually transmitted v no awareness; awareness of the high prevalence of HPV v no
awareness). Participants (n=811) were female students. They were asked to imagine that they had tested
positive for HPV. Outcome measures were expected stigma, shame and anxiety.
Results: Great differences were observed in emotional reactions to imagining testing HPV positive between
the four groups based on knowledge of HPV. Knowledge of the prevalence was associated with lower levels
of stigma, shame and anxiety. Knowledge that HPV is sexually transmitted was associated with higher levels
of stigma and shame, but not anxiety. Women who knew that HPV is sexually transmitted but not that it is
highly prevalent had the highest scores for stigma and shame.
Conclusions: Raising public awareness of the sexually transmitted nature of HPV has the potential to increase
women’s feelings of stigma and shame if they test positive for the virus. However, our findings suggest that
ensuring women’s awareness of HPV being common may reduce these feelings and also reduce anxiety,
perhaps by ‘‘normalising’’ the infection.
H
uman papillomavirus (HPV) is a common sexually
transmitted infection (STI). A recent study in
Manchester, UK, found that 40% of women aged 20–
24 years tested positive for high-risk types of the virus.
1 Strong
evidence for the role of persistent high-risk HPV in the
aetiology of cervical cancer
2 has resulted in HPV testing being
recommended as part of cervical screening in the US, and work
is under way to consider its role in the National Screening
Programme in the UK. Prophylactic HPV vaccination has
recently been licensed for use in Europe
3 and is recommended
for girls aged 11–12 years in the US.
4
Despite the enormous progress in research on HPV, most of
the general public remain unaware of the virus.
5 But inevitably,
as testing and vaccination become more widely used, public
awareness will grow, and this could change the way that
cervical cancer is perceived. Some researchers and clinicians
have expressed concern that greater public awareness of the
link with HPV could lead to stigmatisation of cervical cancer
and perhaps even reluctance to attend for screening because of
the sexually transmitted nature of the virus. This idea is
consistent with studies of screening for other STIs (eg,
chlamydia,
6 gonorrhoea and HIV
7) and has received some
support from qualitative studies of HPV testing. Women testing
positive for HPV in the context of cervical screening report
feelings of stigma and shame, but only when they are aware
that the virus is sexually transmitted.
8 There is also evidence
that receiving a positive HPV result is associated with higher
anxiety than simply having an abnormal smear result.
91 0
One way of reducing negative feelings may be to emphasise
the high prevalence of HPV, thereby ‘‘normalising’’ infection.
This is consistent with theories of stigma which propose that
‘‘standards … derive in part from the prevalence of the
phenomenon that is being judged’’.
11 Experimental research
has also shown that infections perceived to be common are
judged to be less serious than those perceived to be rare,
12 so
anxiety about HPV might be less if it were known to be
common. In addition, qualitative work with HPV positive
women indicates that understanding the high prevalence of the
virus may reduce feelings of stigma and shame.
8 If this
observation can be confirmed in quantitative research, it has
implications for public health messages about HPV.
This study examined differences in women’s expected
responses to testing positive for HPV. Information about the
cause and prevalence of the virus was manipulated to test two
hypotheses:
1. Women who know that HPV is sexually transmitted will
expect to experience higher levels of stigma, shame and
anxiety if they test positive for the virus than women who
are not aware of the mode of transmission.
2. Women who are aware of the high prevalence of HPV
infection will expect to experience lower levels of stigma,
shame and anxiety than women who underestimate the
prevalence of infection.
METHODS
Study design
The study was web based, using a quasi-experimental design to
manipulate knowledge of HPV. All participants were provided
with basic information about HPV and cervical cancer (points
1–5 in box 1), but details of the mode of transmission and the
prevalence were manipulated so women received: (1) no
additional information; (2) point 6 (prevalence) only; (3) point
7 (transmission) only; or (4) points 6 and 7.
Abbreviations: HPV, human papillomavirus; STI, sexually transmitted
infection
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Participants were female students at a London university. A
recruitment email was sent to all students with a link to the
website where the questionnaire could be completed online.
Power calculations based on pilot work indicated that a sample
size of at least 150 in each of the four groups would give 80%
power to detect a small effect size for between-group
differences in stigma, shame and anxiety scores, with a
significance level of 0.05. A total of 909 female participants
completed the questionnaire in the first 7 days that it was
online, after which the website was inactivated.
Measures
Stigma, shame and anxiety
Participants were asked to imagine that they had been tested
for HPV and the result had been positive. They then answered
questions relating to how they would expect to feel in this
situation and how other people would behave towards them.
The 17 items (table 1) measuring various aspects of stigma,
shame and anxiety were adapted from work by Cunningham et
al
13 14 on other STIs, and qualitative work in the HPV field. All
items were rated on a 4-point scale. Factor analysis of pilot data
(n=90) yielded three scales with good internal reliability.
Factor analysis in this sample confirmed the three-factor
structure: stigma (8 items, a=0.90), shame (5 items,
a=0.87) and anxiety (4 items, a=0.73).
Knowledge of prevalence and sexually transmitted
nature of HPV
Two questions were used to assess knowledge of HPV at the end
of the survey; both were multiple-choice questions with one
correct answer. The first question asked ‘‘What do you think
causes HPV?’’. Participants could select one of eight answers,
including the correct option ‘‘HPV is sexually transmitted’’. The
second question asked ‘‘About how many people do you think
will get HPV at some point in their lives?’’. Participants had to
choose a response between 0% and 100%, with an additional
option for ‘‘don’t know’’. Answers from 60% to 100% were
coded as correct for the purposes of this study because all these
responses indicated awareness of the high prevalence of HPV.
i
We also asked participants whether they had ever heard of HPV
before taking part in the study.
Demographic characteristics
Demographic characteristics were assessed with simple ques-
tions on age, marital status, subject of study, religion, practising
of religion and ethnicity.
Procedure
An email was circulated to all students of University College
London asking them to complete the online survey about
‘‘reactions to health information’’ and informing them that
participants would be entered into a £100 prize draw. The
survey was set up so that participants were randomly allocated
to one of the four information conditions described earlier.
Information was presented in bullet-point form, and partici-
pants were asked to click a box next to each point to indicate
they had read it before moving on to the next stage. The
response section was designed so that participants could not
progress to the next page until all questions had been
completed, so there were no missing data. Times of starting
and finishing were recorded so that people taking an
excessively long time could be excluded from analyses, thus
minimising the chance of including people who were looking
up information about HPV or discussing the survey as they
were doing it. Data were captured in an Access file and
exported to SPSS V.13 for analysis.
RESULTS
Sample
The mean time taken to complete the survey was ,8 min. After
eliminating major outliers (ie, those taking .1 h), we excluded
anyone whose time was more than three standard deviations
above the mean (n=24). Participants who were .30 years old
(n=70) or were not students (n=4) were also excluded to
keep the sample homogeneous. The final sample used for
analysis comprised 811 participants. Table 2 shows the
demographic characteristics of the sample.
Knowledge categorisation
Because we were interested in women’s actual knowledge of
HPV, rather than the information they had been given, we
categorised participants on the basis of the two knowledge
questions completed at the end of the survey—that is, whether
they knew that HPV is sexually transmitted and whether they
were aware of the high lifetime prevalence of the virus.
Classification in this way generated four knowledge groups
(box 2).
Most of the sample (58%) reported having heard of HPV
before, so knowledge did not correspond exactly with the
information that women had been given.
Between-group differences in stigma, shame and
anxiety
Table 1 shows the number of people in each group who
responded positively (ie, with a score of 3–4 out of 4) to each
item. x
2 tests found differences between groups for all the items
on the shame and anxiety scales, and for five of the eight items
on the stigma scale.
Total scores were calculated for the three outcome scales:
stigma, shame and anxiety. These were standardised to take
account of the different number of items in each scale. Figure 1
shows the scores for each outcome for the four knowledge groups.
One way analysis of variance
One way analysis of variance confirmed that stigma
(F3,807=5.31, p=0.001), shame (F3,807=17.60, p,0.001) and
Box 1 Information on human papilloma virus
provided at the start of the survey
1. A virus called human papillomavirus (HPV) is now known
to be involved in the development of cervical cancer
(cancer of the cervix or neck of the womb).
2. For most women, the immune system clears the virus and
there are no health problems associated with it.
3. If infection persists, it can lead to abnormalities in the cells
of the cervix.
4. Regular attendance for cervical smear tests can help to
detect the cell changes that are caused by HPV. These can
then be treated effectively.
5. Both men and women can have the virus, but it rarely
causes any problems for men.
6. It is thought that around 70% of people will be infected
with HPV at some point during their lives—it is very
common.
7. The virus is sexually transmitted.
iOnly 2 participants endorsed 100% and 11 endorsed 90%, so most
women in this group were within 10% of the correct answer.
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knowledge groups.
We used retrospective analyses (Scheffe ´ tests) to examine
differences in means between the four groups on each outcome
measure, and identify where the between-group differences
occurred. Stigma was significantly higher in the ‘‘STI only’’
than in the ‘‘Prevalence only’’ group (mean difference 2.31,
p=0.004). Shame was higher in the ‘‘STI only’’ group than in
the ‘‘No knowledge’’, ‘‘Prevalence only’’ and ‘‘STI and
prevalence’’ groups (mean differences were 3.97 (p,0.001),
5.52 (p,0.001) and 1.89 (p=0.036), respectively). Shame was
also significantly higher in the ‘‘STI and prevalence’’ group than
in the ‘‘Prevalence only’’ group (mean difference 3.64,
p,0.001). Anxiety was significantly higher in the ‘‘No knowl-
edge’’ and ‘‘STI only’’ groups than in the ‘‘STI and prevalence’’
group (mean differences were 2.77 (p,0.001) and 2.38
(p,0.001), respectively).
Two-by-two analysis of variance
A2 62 analysis of variance was used to look at the effects of
knowledge of STI and its prevalence, and to see whether there
was an interaction between them. Knowledge of STI was
significantly associated with stigma (F1,807=7.70, p=0.001)
and shame (F1,807=44.83, p,0.001) but not with anxiety.
Prevalence knowledge was significantly associated with stigma
(F1,807=9.18, p=0.003), shame (F1,807=11.24, p=0.001) and
anxiety (F1,807=27.56, p,0.001). The interaction between the
two knowledge variables was not significant for any of the
outcomes.
To rule out the possibility that between-group differences
might be attributable to demographic factors, we repeated the
262 analyses controlling for demographic differences between
the groups. There were between-group differences in age
(x
2
6=13.23, p=0.04), subject being studied (x
2
6=65.17,
p,0.001) and previous awareness of HPV (x
2
3=94.77,
p,0.001), but not in marital status, ethnic group or practising
of religion. When the three demographic factors were entered
as covariates, the pattern of associations was unchanged.
DISCUSSION
This study was designed to test two hypotheses: (1) women
who know that HPV is sexually transmitted will expect to
experience higher levels of stigma, shame and anxiety if they
test positive than women who are not aware of the mode of
transmission; and (2) women who are aware of the high
prevalence of HPV infection will expect to experience lower
levels of stigma, shame and anxiety than women who under-
estimate the prevalence of infection. Participants were asked to
think hypothetically about testing positive for HPV, and were
given varying amounts of information about the virus to ensure
that we could divide them according to their knowledge into
four groups varying in both prevalence and mode of transmis-
sion.
In line with our first hypothesis, awareness that HPV is
sexually transmitted was associated with significantly higher
levels of stigma and shame, indicating that women respond to
HPV in a way similar to other STIs. This is consistent with
previous qualitative findings.
8 However, knowledge of STI did
not affect anxiety, and the pattern of results in fig 1 indicates
that higher knowledge is associated with lower anxiety: women
who were aware of both the prevalence and cause of HPV were
the least anxious. Women receiving less information may have
focused more on the link between HPV and cervical cancer, so
their higher anxiety reflected concerns about cancer rather than
HPV or sexual transmission.
We also found support for our second hypothesis; knowledge
of prevalence had considerable associations with all three
outcome measures, suggesting that the high prevalence of HPV
is important information to convey to women undergoing HPV
testing. The lower stigma and shame scores in the women who
were aware of the high prevalence of HPV suggest that this
information might have a ‘‘normalising’’ effect. The lower
anxiety in this group is consistent with previous experimental
work which has found that common illnesses are perceived as
less serious.
12
The retrospective tests showed important differences
between the ‘‘STI only’’ group and the ‘‘STI and prevalence’’
Table 1 Between-group differences in response to each item (number of respondents agreeing with each item with percentages in
brackets)
Scale/items
Group 1, no
knowledge
(n=138)
Group 2,
STI only
(n=245)
Group 3,
prevalence only
(n=121)
Group 4, STI
and prevalence
(n=307)
x
2 (df) for
difference
Stigma (Agree/strongly agree)
People would avoid me 22 (15.9) 36 (14.7) 8 (6.6) 35 (11.4) 6.8 (3), NS
People would think badly of me 32 (23.2) 90 (36.7) 21 (17.4) 100 (32.6) 18.5 (3), p,0 001
People would blame me 25 (18.1) 89 (36.3) 13 (10.7) 106 (34.5) 38.7 (3), p,0.001
People would think I was unclean 40 (29.0) 81 (33.1) 32 (26.4) 95 (30.9) 1.9 (3), NS
People would not want to be friends with me 7 (5.1) 14 (5.7) 2 (1.7) 9 (2.9) 5.0 (3), NS
People would not want to have a sexual
relationship with me
78 (56.5) 168 (68.6) 68 (56.2) 183 (59.6) 8.5 (3), p=0.04
People would be uncomfortable around me 34 (24.6) 48 (19.6) 18 (14.9) 41 (13.4) 9.9 (3), p=0.02
People would be angry with me 7 (5.1) 25 (10.2) 4 (3.3) 18 (5.9) 8.0 (3), p=0.05
Shame (Quite/very)
How responsible would you feel? 44 (31.9) 135 (55.1) 34 (28.1) 141 (45.9) 33.4 (3), p,0.001
How ashamed would you feel? 22 (15.9) 67 (27.3) 12 (9.9) 66 (21.5) 17.2 (3), p=0.001
How embarrassed would you feel? 33 (23.9) 85 (34.7) 16 (13.2) 85 (27.7) 19.7 (3), p,0.001
How guilty would you feel? 13 (9.4) 61 (24.9) 9 (7.4) 55 (17.9) 24.5 (3), p,0.001
How disappointed in yourself would you feel? 36 (26.1) 93 (38.0) 21 (17.4) 90 (29.3) 17.8 (3), p,0.001
Anxiety (Quite/very)
How anxious would you feel? 101 (73.2) 179 (73.1) 72 (59.5) 159 (51.8) 34.9 (3), p,0.001
How scared would you feel? 81 (58.7) 136 (55.5) 54 (44.6) 118 (38.4) 23.7 (3), p,0.001
How angry would you feel? 28 (20.3) 71 (29.0) 20 (16.5) 73 (23.8) 8.1 (3), p=0.04
People would pity me 79 (57.2) 100 (40.8) 57 (47.1) 108 (35.2) 20.4 (3), p,0.001
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shame and anxiety. Also important is the fact that among
women who were aware that HPV is highly prevalent, also
knowing it to be sexually transmitted was not associated with a
significant increase in stigma or anxiety, although shame scores
were higher in the group that knew that HPV is sexually
transmitted. This supports the importance of ensuring that
women are made aware of the high prevalence of HPV, given
that they will likely be informed about its mode of transmis-
sion.
Provision of information in this study did not correspond
precisely to knowledge because some women had prior
awareness of HPV and were able to answer the knowledge
questions correctly, without having been provided with the
relevant information. Some women also answered the ques-
tions incorrectly, despite having been provided with the
information (11% of those given causal information and 13%
of those given prevalence information). This shows that merely
providing women with written information is not enough to
ensure understanding (even in the short term), especially in an
ethnically diverse group like our sample,
ii and that further
research is needed to find ways of communicating information
about HPV effectively.
This study has several limitations. Participants had not
actually taken part in HPV testing, so their responses to a
positive result were hypothetical. Although this provides an
indication of the association between knowledge of HPV and
the effect of a test result, we cannot be certain that these results
would generalise to a clinical setting. However, the results are
consistent with previous qualitative research on women who
had tested positive for HPV.
8 The use of a student sample, and
especially one made up largely of science and medical students,
may limit the generalisability of the findings. Students are an
important group to study, given the high prevalence of HPV
infection in young women,
1 but future research might target
those from non-medical specialties, which would probably
reduce the high awareness of HPV among participants. We may
have preferentially recruited women who knew about HPV as
the front page of the survey mentioned the virus and may have
been disconcerting to those who had not heard of it, but we
tried to minimise the effect this might have had by using actual
knowledge of HPV to categorise participants for analysis, and
by controlling for prior awareness in the analyses.
Implications
Our findings indicate that public health messages that raise
women’s awareness of the sexually transmitted nature of HPV
may increase their feelings of stigma and shame if they test
positive for the virus. But ensuring that women are aware that
HPV is highly prevalent seems to reduce these negative feelings,
and to reduce overall anxiety. If these findings can be replicated
in women taking part in HPV testing, they point to the need for
an emphasis on information about the high prevalence of HPV
in public health messages and indicate that this information on
prevalence could mitigate most of the negative psychosocial
consequences of publicising the fact that HPV is sexually
transmitted.
Table 2 Demographic characteristics of the sample
(n=811)
n (%)
Age (years)
18–20 251 (30.9)
21–23 310 (38.2)
24–30 250 (30.9)
Marital status
Single 622 (76.7)
Married/cohabiting 185 (22.8)
Separated/divorced 4 (0.5)
Ethnic group
Asian/Asian British 98 (12.1)
Black/black British 18 (2.2)
Mixed 39 (4.8)
Chinese 61 (7.5)
White British 384 (47.3)
White other 171 (21.1)
Other 19 (2.3)
Do not wish to answer 21 (2.6)
Practising religion
No religion 229 (36.9)
Yes, practising 241 (29.7)
Stated religion but not practising 259 (31.9)
Missing* 12 (1.5)
Subject being studied
Arts 308 (38.0)
Sciences (excluding medicine) 326 (40.2)
Medicine 177 (21.8)
Previous awareness of HPV
Yes 471 (58.1)
No 340 (41.9)
*These participants stated a religion but answered ‘‘NA’’ to whether they
were practising, making it impossible to code them in this variable.
Box 2 Knowledge categorisation into four groups
N Group 1 (n=138): No knowledge of prevalence or
sexual transmission (unaware of the prevalence or that
human papilloma virus (HPV) is sexually transmitted).
N Group 2 (n=245): sexually transmitted infection (STI)
only (aware that HPV is sexually transmitted but unaware
of its high prevalence).
N Group 3 (n=121): prevalence only (aware of the high
prevalence of HPV but unaware that it is sexually
transmitted).
N Group 4 (n=307): STI and prevalence (aware of both the
high prevalence and the mode of transmission).
0
5
10
15
20
25
30
M
e
a
n
 
s
c
o
r
e
 
w
i
t
h
 
s
t
a
n
d
a
r
d
 
e
r
r
o
r
Stigma Shame Anxiety
No knowledge STI only
Prevalence only STI and prevalence
Figure 1 Mean scores for stigma, shame and anxiety for each group, with
standard error bars.
iix2 tests confirmed that those answering the questions wrong despite
having been provided with the relevant information were more likely to be
from non-white ethnic groups.
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